{"id":"CHEMBL100622","canonicalSmiles":"C[N+](C)(C)CCCCCC[N+](C)(C)C","inchiKey":"VZJFGSRCJCXDSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMETHONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111255","11111256","144205589","170465837","90340749","90340750"],"drugbank":["DB08960"],"chEBI":["5700"]},"childChemblIds":["CHEMBL105608","CHEMBL1405927","CHEMBL2106279","CHEMBL332524","CHEMBL3229240","CHEMBL121721","CHEMBL2146097"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1008","canonicalSmiles":"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1","inchiKey":"UIEATEWHFDRYRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPRIDIL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bepadin","Bepridil","Vascor"],"crossReferences":{"PubChem":["104171114","124879417","124879419","144203640","170465240","26755663","26755664","50110980","90341574"],"Wikipedia":["Bepridil"],"drugbank":["DB01244"],"chEBI":["3061"]},"childChemblIds":["CHEMBL1257078","CHEMBL1200382"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000075461","ENSG00000157388","ENSG00000142408","ENSG00000165995","ENSG00000100346","ENSG00000157445","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000198216","ENSG00000167535","ENSG00000105605","ENSG00000006116","ENSG00000007402","ENSG00000081248","ENSG00000102001","ENSG00000151062","ENSG00000108878","ENSG00000130433","ENSG00000006283","ENSG00000075429","ENSG00000182389","ENSG00000141837","ENSG00000196557","ENSG00000153956","ENSG00000067191"],"count":26},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for cardiovascular disease."}
{"id":"CHEMBL104943","canonicalSmiles":"NCCO","inchiKey":"HZAXFHJVJLSVMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOETHANOLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Monoethanolamine","Monoethanolamine oleate"],"crossReferences":{"PubChem":["144213981","17389575"],"Wikipedia":["Ethanolamine"],"drugbank":["DB03994"],"chEBI":["16000"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1086445","canonicalSmiles":"C/C=C/C=O","inchiKey":"MLUCVPSAIODCQM-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROTONALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crotonaldehyde"],"crossReferences":{"PubChem":["17389091"],"Wikipedia":["Crotonaldehyde"],"drugbank":["DB04381"],"chEBI":["41607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1091644","canonicalSmiles":"C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1","inchiKey":"PKCDDUHJAFVJJB-VLZXCDOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINSITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-7487","Linsitinib","OSI-906","OSI-906AA"],"crossReferences":{"drugbank":["DB06075"]},"count":12,"linkedTargets":{"rows":["ENSG00000140443","ENSG00000171105"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0006859","EFO_0000174","MONDO_0008170","EFO_0000182","MONDO_0007254","EFO_0000702","EFO_0000673","EFO_1000796","EFO_0003060","EFO_0000181","EFO_1001951"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL1095097","canonicalSmiles":"COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13","inchiKey":"JUKPWJGBANNWMW-VWBFHTRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPLERENONE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eplerenone","Inspra"],"synonyms":["Eplerenone","SC-66110","SC-6611O"],"crossReferences":{"DailyMed":["eplerenone"],"PubChem":["144205299","170465283","26754514"],"Wikipedia":["Eplerenone"],"drugbank":["DB00700"],"chEBI":["31547"]},"count":15,"approvedIndications":["EFO_0003144","EFO_0000373","EFO_0000319","EFO_0000612","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0000275","MONDO_0000153","EFO_0000318","EFO_0000401","EFO_0001645","MONDO_0007254","EFO_0000373","EFO_0000319","EFO_1001461","EFO_0000537","Orphanet_98896","EFO_0009784","EFO_0000195","EFO_0003896","EFO_0008519","EFO_0003144","EFO_0003884","EFO_0009363","EFO_1002032","EFO_0000612","EFO_1001207","EFO_0001360","EFO_0000400","EFO_1000899"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 5 approved and 10 investigational indications."}
{"id":"CHEMBL109612","canonicalSmiles":"CCCCn1c(Cc2cccc(OC)c2)nc2c(N)ncnc21","inchiKey":"BWLWUGBHOXIUBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109612","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03809"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1098000","canonicalSmiles":"COc1ccccc1[C@@]1(N2C[C@H](O)C[C@H]2C(=O)N(C)C)C(=O)N(S(=O)(=O)c2ccc(O[11CH3])cc2OC)c2ccc(Cl)cc21","inchiKey":"NJXZWIIMWNEOGJ-BHWIVFNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SSR-149415","maximumClinicalTrialPhase":0,"parentId":"CHEMBL582857","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SSR-149415"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL113381","canonicalSmiles":"O=S(=O)(Nc1cccc(B(O)O)c1)c1cc(S(=O)(=O)c2ccccc2)cs1","inchiKey":"YZOKHYPIQNIFRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02858"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1180004","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)C","inchiKey":"VICYBMUVWHJEFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1180004","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02779"],"chEBI":["41378"]},"childChemblIds":["CHEMBL1884887","CHEMBL109873"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1192517","canonicalSmiles":"CNCCCCOc1ccccc1Cc1ccccc1","inchiKey":"QSQQPMHPCBLLGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFEMELANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifemelane","Bifemelane hydrochloride"],"crossReferences":{"PubChem":["11113692","144204477","170465900"],"drugbank":["DB13550"]},"childChemblIds":["CHEMBL543763"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL119625","canonicalSmiles":"O=C(O)Cn1c(=O)c(=O)[nH]c2cc([N+](=O)[O-])c(-n3ccnc3)cc21","inchiKey":"SPXYHZRWPRQLNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZONAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["YM 872 ANHYDROUS","YM-872","YM-872 ANHYDROUS","YM872","YM872 ANHYDROUS","Zonampanel"],"count":1,"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["HP_0002140","EFO_0000712"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1200331","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)(O)O.NC(CO)(CO)CO","inchiKey":"QZJIMDIBFFHQDW-LMLSDSMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOMYCIN TROMETHAMINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1757","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monuril","Monurol"],"synonyms":["Fosfomycin trometamol","Fosfomycin tromethamine","Z 1282","Z-1282"],"crossReferences":{"DailyMed":["fosfomycin%20tromethamine"]},"count":3,"approvedIndications":["EFO_0003103"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for urinary tract infection and has 2 investigational indications."}
{"id":"CHEMBL1200494","canonicalSmiles":"Cl.N=C(N)NC(=O)Cc1c(Cl)cccc1Cl","inchiKey":"DGFYECXYGUIODH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANFACINE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL862","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akfen","Estulic","Guanfacine hydrochloride","Intuniv","Tenex"],"synonyms":["BS 100-141","BS-100-141","Guanfacine hydrochloride","SPD503"],"crossReferences":{"DailyMed":["guanfacine%20hydrochloride"],"PubChem":["11532959","144203710","170465381","50106306","56422899"]},"count":1,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","HP_0100543","EFO_0000692","EFO_0005411"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for attention deficit hyperactivity disorder."}
{"id":"CHEMBL1200522","canonicalSmiles":"COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1","inchiKey":"XNEFYCZVKIDDMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVOBENZONE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsol 1789"],"synonyms":["Avobenzone","Butyl methoxydibenzoylmethane"],"crossReferences":{"PubChem":["144204980","144209994","170464749","174006249","26748930","93576912"],"Wikipedia":["Avobenzone"],"drugbank":["DB09495"]},"count":1,"approvedIndications":["EFO_0003963"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for freckles."}
{"id":"CHEMBL1200538","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"AKUJBENLRBOFTD-QZIXMDIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE ACETATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betamethasone 21-acetate","Betamethasone acetate"],"crossReferences":{"DailyMed":["betamethasone%20acetate"],"chEBI":["31275"]},"count":8,"approvedIndications":["EFO_0000729","HP_0006536","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","HP_0006536","EFO_0002506","HP_0003419","EFO_0009451","EFO_0009552","HP_0001742","HP_0004798","EFO_0005752","EFO_1001434"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL1200543","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.O=P(O)(O)O","inchiKey":"FLQCEKVTYABVSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANILERIDINE PHOSPHATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201347","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Leritine"],"synonyms":["Anileridine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200649","canonicalSmiles":"CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"WTHRRGMBUAHGNI-LCYNINFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINUPRISTIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Quinupristin","RP 57669","RP-57669"],"crossReferences":{"DailyMed":["quinupristin"],"Wikipedia":["Quinupristin"],"drugbank":["DB01369"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999 and has 1 investigational indication."}
{"id":"CHEMBL1200777","canonicalSmiles":"N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-].[Na+]","inchiKey":"YDTFRJLNMPSCFM-UTONKHPSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROTHYROXINE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL559","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200798","canonicalSmiles":"Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12","inchiKey":"OHHDIOKRWWOXMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRAZODONE HYDROCHLORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL621","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desyrel","Molipaxin","Molipaxin cr","Oleptro","Trazodone hydrochloride","Trialodine"],"synonyms":["AF-1161","NSC-292811","Trazodone hydrochloride"],"crossReferences":{"DailyMed":["trazodone%20hydrochloride"],"PubChem":["124891691","144203837","144213002","170465234","26747679","50107085","56423658","855917"],"chEBI":["9655"]},"count":3,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0000253"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200828","canonicalSmiles":"Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1","inchiKey":"WBCWFMFZMRFRLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCRIMINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201227","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pagitane"],"synonyms":["Cycrimine HCl","Cycrimine hydrochloride"],"crossReferences":{"chEBI":["59693"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200853","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C","inchiKey":"JGMOKGBVKVMRFX-HQZYFCCVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYDROGESTERONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duphaston","Duphaston-hrt","Gynorest"],"synonyms":["Dydrogesterone","Isopregnenone","NSC-92336"],"crossReferences":{"PubChem":["144203980","170465104","56463092"],"drugbank":["DB00378"],"chEBI":["31527"]},"count":7,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MONDO_0041161","EFO_0000545","EFO_0000731","HP_0000138","MONDO_0014769","EFO_0008560","EFO_1000237","EFO_0003917","EFO_0003922","EFO_0002950","EFO_1000954"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 7 investigational indications."}
{"id":"CHEMBL1200868","canonicalSmiles":"Nc1ccc(C(=O)Oc2ccccc2)c(O)c1","inchiKey":"DNVVZWSVACQWJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYL AMINOSALICYLATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pheny-pas-tebamin"],"synonyms":["Fenamisal","Phenyl aminosalicylate"],"crossReferences":{"PubChem":["144205091","170465273","26749950"],"drugbank":["DB06807"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201059","canonicalSmiles":"CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1.Cl","inchiKey":"SARMGXPVOFNNNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROGUANIDE HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1377","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paludrine"],"synonyms":["336-U-50","336U50","Chlorguanide hydrochloride","Chloroguanide hydrochloride","GW AH7673A","GW-AH7673A","GWAH7673A","M-4888","NSC-12977","NSC-26614","Proguanil","Proguanil chloride","Proguanil hydrochloride","RP-3359","SN-12837"],"crossReferences":{"DailyMed":["proguanil%20hydrochloride"],"PubChem":["144204027","170464800","56463664"]},"count":3,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for malaria and has 2 investigational indications."}
{"id":"CHEMBL1201096","canonicalSmiles":"[81Kr]","inchiKey":"DNNSSWSSYDEUBZ-OIOBTWANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KRYPTON KR 81M","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1233877","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Krypton kr 81 m gas generator","Mpi krypton 81m generator"],"synonyms":["81mkr","Krypton (81mkr) gas","Krypton kr 81m","Krypton, kr-81m"],"crossReferences":{"drugbank":["DB09443"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201115","canonicalSmiles":"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl","inchiKey":"GEKNCWBANDDJJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESMOLOL HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL768","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"year":2007},"tradeNames":["Brevibloc","Esmolol hydrochloride"],"synonyms":["ASL-8052","Esmolol hydrochloride"],"crossReferences":{"DailyMed":["esmolol%20hydrochloride"],"PubChem":["144207045","170465277","49681641"],"chEBI":["4857"]},"count":4,"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["HP_0100543","EFO_1001459","HP_0000138","EFO_0005251"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 investigational indications. It was withdrawn in United States  in 2007."}
{"id":"CHEMBL1201119","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-].[Na+]","inchiKey":"SBXXSUDPJJJJLC-YDALLXLXSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"LIOTHYRONINE SODIUM","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1544","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cynomel","Cytomel","Liothyronine sodium","Tertroxin","Thybon","Triiodothyronine","Triiodothyronine,evans","Triostat"],"synonyms":["Liothyronine sodium","Liothyronine sodium salt","NSC-80774","T3 (liotrix)","Triiodothyronine sodium, levo"],"crossReferences":{"DailyMed":["liothyronine%20sodium"],"PubChem":["144212831","855617"],"Wikipedia":["Liothyronine"],"chEBI":["6484"]},"count":7,"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_0003885","EFO_0006859","EFO_0003841","EFO_0005207","HP_0030680","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201496","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ASPART","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fiasp","Fiasp flextouch","Fiasp penfill","Ins novorapid","Novolog","Novolog flexpen","Novolog flextouch","Novolog innolet","Novolog penfill"],"synonyms":["B28-ASP-INSULIN","INA-X14","INSULIN X14","Insulin aspart","Insulin aspart recombinant"],"crossReferences":{"DailyMed":["insulin%20aspart","insulin%20aspart%20recombinant"],"DrugCentral":["4981"],"Wikipedia":["Insulin_aspart"]},"count":11,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0001645","EFO_0000249","HP_0002153","Orphanet_586","EFO_0000537","EFO_0000565","EFO_0003914","EFO_0004593","EFO_0001359","HP_0003074","EFO_0000574","EFO_0001360","EFO_0000400"],"count":14},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for diabetes mellitus and has 10 investigational indications."}
{"id":"CHEMBL1201540","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humulin n","Novolin n"],"synonyms":["Insulin susp isophane recombinant human"],"crossReferences":{"DailyMed":["insulin%20susp%20isophane%20recombinant%20human"]},"count":7,"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0001359","HP_0003074","EFO_0001645","EFO_1000897","EFO_0001360","EFO_0000400","EFO_0000537"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 7 investigational indications."}
{"id":"CHEMBL1201544","drugType":"Unknown","blackBoxWarning":true,"name":"IRON DEXTRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Armidexan","Cosmofer","Dexferrum","Ferran 100","Ferrum","Imferon","Infed","Iron dextran","Nonemic","Proferdex"],"synonyms":["Iron dextran"],"crossReferences":{"DailyMed":["iron%20dextran"]},"count":4,"approvedIndications":["EFO_0004272","EFO_0001070","HP_0001891"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201624","drugType":"Unknown","blackBoxWarning":false,"name":"BERACTANT","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Survanta"],"synonyms":["A-60386X","Beractant"],"crossReferences":{"DailyMed":["beractant"],"DrugCentral":["5108"],"Wikipedia":["Beractant"]},"count":2,"approvedIndications":["EFO_1000644"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for newborn respiratory distress syndrome and has 1 investigational indication."}
{"id":"CHEMBL1201826","drugType":"Enzyme","blackBoxWarning":true,"name":"IDURSULFASE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["EC 3.1.6.13","EC-3.1.6.13","GC1111","Iduronate-2-sulfatase","Idursulfase"],"crossReferences":{"DailyMed":["idursulfase"],"DrugCentral":["4918"],"Wikipedia":["Idursulfase"]},"count":2,"approvedIndications":["Orphanet_580"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for mucopolysaccharidosis type 2 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201832","drugType":"Protein","blackBoxWarning":false,"name":"ROMIPLOSTIM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nplate"],"synonyms":["AMG 531","Romiplostim"],"crossReferences":{"DailyMed":["romiplostim"],"DrugCentral":["4996"],"Wikipedia":["Romiplostim"]},"count":11,"approvedIndications":["MP_0001914","EFO_0007160"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MP_0001914","EFO_0007160","Orphanet_906","MONDO_0008170","MONDO_0043768","EFO_0000574","EFO_0000313","HP_0001915","EFO_0005952","MONDO_0018896","HP_0001873","EFO_0000311"],"count":13},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for autoimmune thrombocytopenic purpura and hemorrhage and has 9 investigational indications."}
{"id":"CHEMBL121915","canonicalSmiles":"N[C@@H](Cn1cc(I)c(=O)[nH]c1=O)C(=O)O","inchiKey":"AXXYLTBQIQBTES-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-5-Iodowillardiine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-5-Iodowillardiine"],"crossReferences":{"PubChem":["11113440","50104371"],"Wikipedia":["5-Iodowillardiine"],"drugbank":["DB02818"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231132","canonicalSmiles":"CN(C)C(=O)c1ccc(S(=O)(=O)c2ccc(NC(=O)[C@@](C)(O)C(F)(F)F)c(Cl)c2)cc1","inchiKey":"DTDZLJHKVNTQGZ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231132","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07403"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231248","canonicalSmiles":"CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](OC(=O)c1ccccc1)C2","inchiKey":"GVGYEFKIHJTNQZ-RFQIPJPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THERACYS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206160","144206406"],"drugbank":["DB01515"],"chEBI":["41001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123132","canonicalSmiles":"N[C@@H](Cn1cc(F)c(=O)[nH]c1=O)C(=O)O","inchiKey":"DBWPFHJYSTVBCZ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-5-Fluorowillardiine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-5-Fluorowillardiine","5-Fluorowillardiine"],"crossReferences":{"PubChem":["11113439"],"Wikipedia":["5-Fluorowillardiine"],"drugbank":["DB02966"],"chEBI":["42549"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232088","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)CC(=O)[O-]","inchiKey":"DVEKCXOJTLDBFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232088","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211750"],"drugbank":["DB07631"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233464","canonicalSmiles":"O=CCc1ccccc1","inchiKey":"DTUQWGWMVIHBKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLACETALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208780","144213262"],"drugbank":["DB02178"],"chEBI":["16424"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234088","canonicalSmiles":"O=C1Nc2ccccc2/C1=C/Nc1ccc(S(=O)(=O)Nc2nccs2)cc1","inchiKey":"BOMPRXSVSIPRDT-PTNGSMBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234088","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08125"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234293","canonicalSmiles":"C[n+]1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c21","inchiKey":"OGHAROSJZRTIOK-KQYNXXCUSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234293","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03493"],"chEBI":["20794"]},"childChemblIds":["CHEMBL3351034"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235112","canonicalSmiles":"O=C(COP(=O)(O)O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"XPYBSIWDXQFNMH-UYFOZJQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235112","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13863"],"chEBI":["16905"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235287","canonicalSmiles":"N[C@H](CO)Cc1ccccc1","inchiKey":"STVVMTBJNDTZBF-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-PHENYLALANINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576654"],"drugbank":["DB04484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235818","canonicalSmiles":"Nc1nc2cc3nc(NCc4cccs4)[nH]c3cc2c(=O)[nH]1","inchiKey":"IQKMJWDYMFWZRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235818","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237123","canonicalSmiles":"COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC","inchiKey":"GBLRQXKSCRCLBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXACURIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01135"],"chEBI":["4706"]},"childChemblIds":["CHEMBL1237099"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1256361","canonicalSmiles":"CC(C)NNC(=O)c1ccncc1.O=P(O)(O)O","inchiKey":"YPDVTKJXVHYWFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRONIAZID PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL92401","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iproniazid Phosphate"],"crossReferences":{"PubChem":["11533071","50106453","50106454"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256655","canonicalSmiles":"COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12.Cl","inchiKey":"WDISRLXRMMTXEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMSACRINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL43","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amsacrine HCl"],"crossReferences":{"PubChem":["144204763","50105897","56463457"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL127","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12","inchiKey":"DMJNNHOOLUXYBV-PQTSNVLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEROPENEM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Meropenem","Merrem","Merrem iv"],"synonyms":["ICI 194,660","ICI-194660","Meropenem","Meropenem hydrate","Meropenem trihydrate","SM-7338"],"crossReferences":{"DailyMed":["meropenem"],"PubChem":["144204266","170464676","170466350","49681817"],"Wikipedia":["Meropenem"],"drugbank":["DB00760"],"chEBI":["43968"]},"childChemblIds":["CHEMBL4175954"],"count":18,"approvedIndications":["EFO_0003103","EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 15 investigational indications."}
{"id":"CHEMBL1271","canonicalSmiles":"C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1","inchiKey":"XSBSKEQEUFOSDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOLINIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ansolysen","Pentolinium"],"crossReferences":{"Wikipedia":["Pentolinium"],"drugbank":["DB01090"],"chEBI":["347401"]},"childChemblIds":["CHEMBL118902","CHEMBL1356989","CHEMBL1318287"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1289926","canonicalSmiles":"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1","inchiKey":"RITAVMQDGBJQJZ-FMIVXFBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXITINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inlyta"],"synonyms":["AG-013736","AG-13736","Axitinib"],"crossReferences":{"DailyMed":["axitinib"],"PubChem":["124950168","144207146","170466656"],"Wikipedia":["Axitinib"],"drugbank":["DB06626"],"chEBI":["66910"]},"count":39,"approvedIndications":["EFO_0000616","EFO_0000640","EFO_0000681","EFO_0000349","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003891","EFO_0001065","EFO_0000756","EFO_0000681","EFO_1001465","EFO_1000131","EFO_0004252","EFO_0000231","EFO_1001951","MONDO_0001056","EFO_0003860","EFO_0000770","EFO_0000182","EFO_0000673","EFO_0000198","EFO_0000616","EFO_1000508","EFO_0000349","Orphanet_44890","MONDO_0004669","EFO_0000222","EFO_0000313","EFO_1001968","MONDO_0016238","EFO_0004243","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0007143","EFO_0000640","EFO_0003865","EFO_0003841","MONDO_0000544","EFO_0002517","MONDO_0011962","EFO_0004142","MONDO_0002367","EFO_1000796","MONDO_0024880","EFO_0000519","MONDO_0021640","EFO_0000181"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 approved and 34 investigational indications."}
{"id":"CHEMBL13485","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(Cl)cc32)c1C","inchiKey":"XPLJEFSRINKZLC-ATVHPVEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-11652","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-11652"],"crossReferences":{"drugbank":["DB08009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1371412","canonicalSmiles":"CCCOc1ccc2nc(NC(=O)OC)sc2c1","inchiKey":"HLLICFJUWSZHRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOXIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH 21480","Tioxidazole"],"crossReferences":{"PubChem":["144205396","29216163"],"drugbank":["DB11472"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1399702","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3cncnc32)[C@H](O)[C@@H]1O","inchiKey":"MRWXACSTFXYYMV-FDDDBJFASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBULARINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nebularine"],"crossReferences":{"PubChem":["26753558","50106200","50106201","90340794"],"drugbank":["DB04440"],"chEBI":["18255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1443","canonicalSmiles":"CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"GPXLMGHLHQJAGZ-JTDSTZFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFCILLIN","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nafcillin","Nallpen","Unipen"],"crossReferences":{"DailyMed":["nafcillin%20sodium"],"Wikipedia":["Nafcillin"],"drugbank":["DB00607"],"chEBI":["7447"]},"childChemblIds":["CHEMBL1200344","CHEMBL1568276"],"count":4,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for bacterial disease and has 3 investigational indications."}
{"id":"CHEMBL1451173","canonicalSmiles":"CC(=O)Oc1cccc(C(=O)O)c1OC(C)=O","inchiKey":"NYIZXMGNIUSNKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYROCETYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diacetylsalicylic acid","Dipyrocetyl"],"crossReferences":{"PubChem":["144205057","26749322"],"drugbank":["DB13839"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1479","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"POZRVZJJTULAOH-LHZXLZLDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DANAZOL","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Danazol","Danocrine"],"synonyms":["Danazol","NSC-270916","WIN 17,757","WIN-17757"],"crossReferences":{"DailyMed":["danazol"],"PubChem":["144205667","144212257","170464884","26757819","49648394"],"TG-GATEs":["127"],"Wikipedia":["Danazol"],"drugbank":["DB01406"],"chEBI":["4315"]},"count":12,"linkedTargets":{"rows":["ENSG00000082175","ENSG00000169083"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","Orphanet_84","EFO_0007160","EFO_0000545","MONDO_0019098","EFO_0001065","EFO_1001366","MONDO_0011962","Orphanet_1775","EFO_0003014","HP_0001915","MONDO_0018896","EFO_0009321"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1487","canonicalSmiles":"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O","inchiKey":"XUKUURHRXDUEBC-KAYWLYCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATORVASTATIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardyl","Lipitor","Prevencor","Sortis","Tahor","Zarator"],"synonyms":["Atorvastatin"],"crossReferences":{"DailyMed":["atorvastatin%20calcium"],"PubChem":["124892211","144212734","29215408"],"Wikipedia":["Atorvastatin"],"drugbank":["DB01076"],"chEBI":["39548"]},"childChemblIds":["CHEMBL393220","CHEMBL1790017","CHEMBL3349878"],"count":14,"approvedIndications":["HP_0003124","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["MONDO_0002492","EFO_0001361","EFO_0000365","EFO_0000275","EFO_0000681","EFO_0000249","HP_0001258","EFO_0005952","EFO_1000984","EFO_0003914","EFO_0008585","EFO_0002690","EFO_0009952","EFO_0003884","EFO_0000676","EFO_1002032","EFO_0004616","EFO_1000961","EFO_0000400","MONDO_0013730","EFO_1000812","EFO_0000180","EFO_0004286","EFO_1001771","EFO_0004197","EFO_0000384","MONDO_0008315","EFO_0000660","EFO_0001422","EFO_0009426","EFO_0006818","MONDO_0000831","EFO_0007328","EFO_0001378","EFO_0000341","EFO_0005672","EFO_0004214","MONDO_0018373","EFO_0003086","HP_0000726","MONDO_0007254","EFO_0004252","EFO_0008568","EFO_0000196","MONDO_0000820","Orphanet_797","EFO_0000616","EFO_0000765","EFO_0004269","EFO_0001645","EFO_0003929","EFO_0000222","EFO_0000319","EFO_1001267","EFO_0004911","EFO_0000537","EFO_0000195","EFO_0003885","EFO_0004517","MONDO_0021661","EFO_0000649","EFO_0000764","Orphanet_79211","MONDO_0011962","EFO_0000519","EFO_0004265","EFO_0004264","EFO_0003869","EFO_0003095","EFO_0003774","EFO_0000266","EFO_0003913","EFO_0000565","EFO_0007160","EFO_0003870","EFO_0000182","EFO_0004208","EFO_0007243","HP_0003124","EFO_0002687","HP_0001919","Orphanet_3389","EFO_0004236","EFO_0004194","Orphanet_413","Orphanet_309005","HP_0002110","HP_0100806","MP_0001845","MONDO_0100096","Orphanet_412","EFO_0000270","EFO_0001359","EFO_0001360","EFO_0000668","Orphanet_232","EFO_0000318","EFO_1001249","MONDO_0002679","EFO_0000373","EFO_0000538","EFO_0004246","EFO_0004211","HP_0000083","Orphanet_68380","EFO_0000474","EFO_1001801","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0000673","EFO_1001993","HP_0003119","EFO_0003047","EFO_0007129","EFO_0008586","EFO_0000685","HP_0002140","EFO_0009783","EFO_0000556","HP_0001647","EFO_0002615","EFO_0000311","MONDO_0004782","EFO_0008583","EFO_0000612","EFO_0003918"],"count":127},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for hypercholesterolemia and cardiovascular disease and has 12 investigational indications."}
{"id":"CHEMBL1501","canonicalSmiles":"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C","inchiKey":"WJOHZNCJWYWUJD-IUGZLZTKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUOCINONIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluocinonide","Fluocinonide emulsified base","Lidex","Lidex-e","Metosyn","Metosyn fapg","Vanos"],"synonyms":["Fluocinolide","Fluocinonide","NSC-101791"],"crossReferences":{"DailyMed":["fluocinonide"],"PubChem":["144203989","170464717","855724"],"Wikipedia":["Fluocinonide"],"drugbank":["DB01047"]},"count":5,"approvedIndications":["EFO_0009552"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000701","EFO_0000676","EFO_0009552","EFO_0000274","EFO_0000305"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for hemorrhoid and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL157604","canonicalSmiles":"COc1ccc(CC(N)=O)cc1","inchiKey":"OLKQIWCQICCYQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL157604","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1615350","canonicalSmiles":"CN(C)CCCC1c2ccccc2Nc2ccc(Cl)cc21","inchiKey":"JFRLWWDJCFYFSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMACRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1982},"tradeNames":[],"synonyms":["Clomacran","SKF-14336-D"],"childChemblIds":["CHEMBL2104136"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1982 due to Hepatotoxicity."}
{"id":"CHEMBL1615807","canonicalSmiles":"CC1(C)C(/C=C/C=C/C=C/C=C2\\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21","inchiKey":"BDBMLMBYCXNVMC-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOCYANINE GREEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1616951","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]2(O)CCC(=O)O","inchiKey":"PBKZPPIHUVSDNM-WNHSNXHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANRENOATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Canrenoic acid"],"crossReferences":{"drugbank":["DB09015"],"chEBI":["50156"]},"childChemblIds":["CHEMBL1371200"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0008585","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1651534","canonicalSmiles":"O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1","inchiKey":"BATCTBJIJJEPHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04457845","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04457845","Pf-04457845"],"crossReferences":{"Wikipedia":["PF-04457845"],"drugbank":["DB12012"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1668","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC","inchiKey":"SZLZWPPUNLXJEA-QEGASFHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESCINNAMINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cinnasil","Moderil"],"synonyms":["Rescinnamine"],"crossReferences":{"PubChem":["56463114"],"Wikipedia":["Rescinnamine"],"chEBI":["28572"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and is indicated for hypertension."}
{"id":"CHEMBL1697775","canonicalSmiles":"OCCSCCCCCCCCCCSCCO","inchiKey":"WRCITXQNXAIKLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIADENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiadenol"],"crossReferences":{"drugbank":["DB13348"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL170721","canonicalSmiles":"CC(=O)C=O","inchiKey":"AIJULSRZWUXGPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLGLYOXAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxo-Propionaldehyde"],"crossReferences":{"Wikipedia":["Methylglyoxal"],"drugbank":["DB03587"],"chEBI":["17158"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1738699","canonicalSmiles":"Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1","inchiKey":"YVPGZQLRPAGKLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N6022","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N6022"],"crossReferences":{"drugbank":["DB12206"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C\\c3scnc3C)CS[C@H]12)c1csc(N)n1","inchiKey":"KMIPKYQIOVAHOP-YLGJWRNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFDITOREN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefditoren"],"crossReferences":{"drugbank":["DB01066"],"chEBI":["59343"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743026","drugType":"Antibody","blackBoxWarning":false,"name":"GEVOKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gevokizumab","XOMA 052","XOMA-052"],"count":10,"linkedTargets":{"rows":["ENSG00000125538"],"count":1},"linkedDiseases":{"rows":["MONDO_0001718","EFO_1001231","EFO_0000685","EFO_0002506","EFO_0009672","EFO_0003780","EFO_0001359","HP_0000999","EFO_0001360","EFO_0003894"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1761","canonicalSmiles":"Cl.OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1","inchiKey":"ZFSPFXJSEHCTTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCYCLIDINE HYDROCHLORIDE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL86715","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arpicolin","Kemadrin","Muscinil"],"synonyms":["Procyclidine HCl","Procyclidine hydrochloride"],"crossReferences":{"PubChem":["144204059","170464805","26748224","26748225","50107359","50107360","56424071","856015"],"Wikipedia":["Procyclidine"],"chEBI":["8449"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955."}
{"id":"CHEMBL1762621","canonicalSmiles":"COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2","inchiKey":"WPTTVJLTNAWYAO-KPOXMGGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARDOXOLONE METHYL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bardoxolone methyl","Bardoxolone methyl ester","CDDO-METHYL ESTER","CDDO-Me","NSC 713200","NSC-713200","RTA 402","RTA-402","Rta-402"],"crossReferences":{"PubChem":["144206780","532003"],"drugbank":["DB05983"]},"count":8,"linkedTargets":{"rows":["ENSG00000104365","ENSG00000132170","ENSG00000079999","ENSG00000116044"],"count":4},"linkedDiseases":{"rows":["Orphanet_63","EFO_0002618","MONDO_0005149","EFO_0001361","MONDO_0100096","EFO_0001642","EFO_0000756","EFO_0000401","EFO_0001421"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1774489","canonicalSmiles":"CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1.Cl","inchiKey":"ISXACXJMJCXVNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1774489","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1738758","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL184618","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"PGBHMTALBVVCIT-VCIWKGPPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRAMYCETIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTIBIOTIQUE EF 185","Framycetin","Neomycin b"],"crossReferences":{"DrugCentral":["4247"],"Wikipedia":["Framycetin"],"drugbank":["DB00452"],"chEBI":["7508"]},"childChemblIds":["CHEMBL3188205","CHEMBL1950493","CHEMBL1275977"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1922094","canonicalSmiles":"Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12","inchiKey":"YOVVNQKCSKSHKT-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APITOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apitolisib","G-038390","G-038390.1","GDC-0980","GDC-0980.1","RG-7422","RG7422","Rg-7422"],"crossReferences":{"drugbank":["DB12180"]},"childChemblIds":["CHEMBL1922103","CHEMBL1922106"],"count":6,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000681","EFO_1001512","MONDO_0007254","EFO_0005952","MONDO_0008315","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2010872","canonicalSmiles":"CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3","inchiKey":"AEULIVPVIDOLIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-11981","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BOL-303213X","CEP-11981","Cep-11981"],"count":2,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000120156"],"count":4},"linkedDiseases":{"rows":["EFO_0000196","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2012522","canonicalSmiles":"CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12.O=C(O)CCC(=O)O","inchiKey":"VETOWAAOXIOBAQ-FTBISJDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-377604","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2012520","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-377604"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2013174","canonicalSmiles":"CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(C)C)n3)nc3c(Cl)c(OCCN4CCOCC4)ccc23)CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@@H]2C[C@@H]2C1)C(C)(C)C)C(=O)O","inchiKey":"OTXAMWFYPMNDME-FQQWJMKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEDROPREVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9451","Vedroprevir"],"crossReferences":{"drugbank":["DB12037"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2024517","canonicalSmiles":"CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl","inchiKey":"GPPJWWMREQHLQT-BHQIMSFRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARIPRAZINE HYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2028019","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vraylar"],"synonyms":["Cariprazine hydrochloride","RGH-188 HCL"],"crossReferences":{"DailyMed":["cariprazine%20hydrochloride"]},"count":2,"approvedIndications":["EFO_0000289","EFO_0000692"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000151577"],"count":2},"linkedDiseases":{"rows":["EFO_0000289","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for schizophrenia and bipolar disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2043025","canonicalSmiles":"COc1ccc2c(c1)C=C1Cn3c-2c(C2CCCCC2)c2ccc(cc23)C(=O)NS(=O)(=O)N(C)CCOCCN(C)C1=O","inchiKey":"UOBYJVFBFSLCTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TMC-647055","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TMC647055","Tmc-647055"],"crossReferences":{"drugbank":["DB11822"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2062257","canonicalSmiles":"Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)C(O)C(O)C(=O)O","inchiKey":"QZHBYNSSDLTCRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIMONIDINE TARTRATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL844","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphagan","Alphagan p","Brimonidine tartrate","Brymont","Lumify","Mirvaso","Qoliana"],"synonyms":["AGN 190342-LF","AGN-190342-LF","AGN-190342LF","Brimonidine d-tartrate","Brimonidine tartrate","OCU-300","OCU300","UK-14304-18","UK-1430418"],"crossReferences":{"DailyMed":["brimonidine%20tartrate"]},"count":12,"approvedIndications":["EFO_1000760","EFO_1001069","EFO_0004190","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","HP_0010783","EFO_1000879","EFO_1000906","MONDO_0008315","HP_0031284","Orphanet_791","EFO_0009606","EFO_0003885","EFO_1000760","EFO_1001022","MONDO_0021698","EFO_0007141","EFO_0000516","EFO_1001893","EFO_0003822"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved and 8 investigational indications."}
{"id":"CHEMBL2070241","canonicalSmiles":"CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O","inchiKey":"FFHBJDQSGDNCIV-MFVUMRCOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BREMELANOTIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bremelanotide"],"synonyms":["Bremelanotide","PT-141","PT-141 FREE BASE"],"crossReferences":{"drugbank":["DB11653"]},"childChemblIds":["CHEMBL4297533"],"count":2,"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","HP_0002018"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 2 investigational indications."}
{"id":"CHEMBL2095211","canonicalSmiles":"C[C@H]1CNCCc2ccc(Cl)cc21.Cl","inchiKey":"ITIHHRMYZPNGRC-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORCASERIN HYDROCHLORIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL360328","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Belviq","Belviq xr"],"synonyms":["APD-356","APD356","Lorcaserin hydrochloride"],"crossReferences":{"DailyMed":["lorcaserin%20hydrochloride"],"chEBI":["65350"]},"count":2,"linkedTargets":{"rows":["ENSG00000147246"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 2 investigational indications."}
{"id":"CHEMBL2103839","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"BUROJSBIWGDYCN-GAUTUEMISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIDAFOROLIMUS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP 23573","AP-23573","AP23573","Deforolimus","MK-8669","Ridaforolimus"],"crossReferences":{"drugbank":["DB06233"],"chEBI":["79700"]},"count":18,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0003869","EFO_0000637","EFO_1001465","MONDO_0007254","EFO_1001968","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0002430","EFO_0000565","EFO_0000564","MONDO_0011962","EFO_0000574","EFO_0001378","EFO_0000691","EFO_0000569","MONDO_0021054"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 18 investigational indications."}
{"id":"CHEMBL2104678","canonicalSmiles":"CCN(CC)C(=O)CSc1ccc(Cl)nn1","inchiKey":"SSLKKMZJCJBOML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZINTAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azintamide","Azinthiamide","ST 9067"],"crossReferences":{"drugbank":["DB13992"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105160","canonicalSmiles":"C[C@@H](N/C(=N\\C#N)Nc1ccc(C#N)cc1)C(C)(C)C","inchiKey":"PGYDRGZVXVVZQC-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAMINIDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-234303","BMS-234303-01","Naminidil"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105657","canonicalSmiles":"C[C@H](O)C(=O)O.Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1","inchiKey":"MHFUWOIXNMZFIW-WNQIDUERSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOZASERTIB LACTATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL572878","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0457","Tozasertib lactate","VX-680"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106409","canonicalSmiles":"CO[C@H]1[C@@H](O)[C@@H](C)O[C@H](O[C@H]2[C@H](Oc3cccc4c(O)c5c(=O)oc6ccc(C)c7c(=O)oc(c34)c5c67)O[C@H](C)[C@H](O)[C@]2(C)O)[C@@H]1N","inchiKey":"MGQRRMONVLMKJL-KWJIQSIXSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ELSAMITRUCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BBM-2478A","BMY-28090","Elsamitrucin"],"crossReferences":{"drugbank":["DB05129"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107085","canonicalSmiles":"Nc1ncnc2c1nc(Cl)n2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O","inchiKey":"CLLFEJLEDNXZNR-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOCLADESINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-CL-CAMP","Adenazole","ICN-1256","NSC-614491","Tocladesine"],"crossReferences":{"drugbank":["DB13046"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107546","canonicalSmiles":"CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N.Cl","inchiKey":"NCEAPFRHADKEHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCINDOLOL HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL321582","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucindolol hydrochloride","MJ 13,105-1","MJ-13105-1"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107549","canonicalSmiles":"CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O","inchiKey":"MTHORRSSURHQPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BINDARIT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF 2838","AF-2838","Bindarit"],"crossReferences":{"PubChem":["174007203"],"drugbank":["DB12739"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107778","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(O)C(C)=O","inchiKey":"SFLXYFZGKSGFKA-XUDSTZEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEGESTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nestorone"],"synonyms":["Segesterone"],"crossReferences":{"drugbank":["DB14584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107845","drugType":"Cell","blackBoxWarning":false,"name":"CARLECORTEMCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stemex"],"synonyms":["Carlecortemcel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108297","drugType":"Enzyme","blackBoxWarning":false,"name":"BUCELIPASE ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucelipase alfa"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108341","drugType":"Antibody","blackBoxWarning":false,"name":"SONTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1402","HUHMFG-1","Sontuzumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108479","drugType":"Enzyme","blackBoxWarning":false,"name":"RANPIRNASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Onconase"],"synonyms":["P-30","P-30 PROTEIN","Ranpirnase"],"count":3,"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108616","drugType":"Antibody","blackBoxWarning":false,"name":"LIBIVIRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hepex-b"],"synonyms":["Libivirumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108638","drugType":"Antibody","blackBoxWarning":false,"name":"RAXIBACUMAB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abthrax"],"synonyms":["Raxibacumab"],"crossReferences":{"DailyMed":["raxibacumab"],"DrugCentral":["4961"]},"count":1,"approvedIndications":["EFO_0000778"],"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for anthrax infection."}
{"id":"CHEMBL2108677","drugType":"Protein","blackBoxWarning":false,"name":"PEGINTERFERON BETA-1A","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biib017","Plegridy"],"synonyms":["BIIB-017","BIIB017","Peginterferon beta","Peginterferon beta-1a"],"crossReferences":{"DailyMed":["peginterferon%20beta-1a"],"DrugCentral":["5137"]},"count":3,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0003885","HP_0000083","EFO_0003929"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for multiple sclerosis and has 2 investigational indications."}
{"id":"CHEMBL2108822","drugType":"Unknown","blackBoxWarning":false,"name":"TYPHOID VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Typhoid vaccine"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108924","drugType":"Unknown","blackBoxWarning":false,"name":"CINNAMON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B1472","Cinnamomum verum","Cinnamomum verum bark","Cinnamomum verum powder","Cinnamomum verum stem bark","Cinnamon","FEMA NO. 2289"],"count":6,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109095","drugType":"Antibody","blackBoxWarning":false,"name":"ERLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Erlizumab","RHUMAB CD18"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109214","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPAGERMANIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-267004","Propagermanium"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109346","drugType":"Antibody","blackBoxWarning":false,"name":"AME-133V","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AME-133V","LY-2469298"],"count":1,"linkedTargets":{"rows":["ENSG00000160255"],"count":1},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109428","drugType":"Antibody","blackBoxWarning":false,"name":"TRX-518","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRX-518","Trx-518"],"count":5,"linkedTargets":{"rows":["ENSG00000186891"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","MONDO_0008170","MONDO_0007254","MONDO_0008315"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109478","drugType":"Antibody","blackBoxWarning":false,"name":"DAPIROLIZUMAB PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-7657","CDP7657","Dapirolizumab pegol"],"count":1,"linkedTargets":{"rows":["ENSG00000102245"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109616","drugType":"Antibody","blackBoxWarning":false,"name":"ABX-IL8","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-IL8","Abx-il8"],"count":1,"linkedTargets":{"rows":["ENSG00000169429"],"count":1},"linkedDiseases":{"rows":["EFO_0006505"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109649","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7594","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7594"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110789","canonicalSmiles":"CO[C@]12C=C[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"VSKIOMHXEUHYSI-KNLIIKEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPRENORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyprenorphine"],"crossReferences":{"drugbank":["DB01480"]},"childChemblIds":["CHEMBL2106063"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111051","canonicalSmiles":"C#CCO[C@H]1CN2CCC1CC2","inchiKey":"XVFJONKUSLSKSW-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALSACLIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talsaclidine"],"crossReferences":{"drugbank":["DB12287"]},"childChemblIds":["CHEMBL2107204"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2134724","canonicalSmiles":"CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O.[Br-]","inchiKey":"KEWHKYJURDBRMN-XSAPEOHZSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRATROPIUM BROMIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1621597","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atrovent","Atrovent aerocaps","Atrovent fte","Atrovent hfa","Atrovent udvs","Ipratrop","Ipratrop steripoule","Ipratropium bromide","Respontin","Rinatec","Tropiovent"],"synonyms":["Ipratropium bromide","Ipratropium bromide hydrate","Ipratropium bromide monohydrate","SCH 1000-BR-MONOHYDRATE","SCH-1000-BR-"],"crossReferences":{"DailyMed":["ipratropium%20bromide"],"PubChem":["56462997"]},"count":11,"approvedIndications":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000341","HP_0001742","EFO_0007214"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0001361","Orphanet_1764","EFO_0000270","EFO_0000464","EFO_0002508","EFO_0006505","EFO_1002018","EFO_0000341","HP_0025428","HP_0002307","HP_0001742","EFO_0007214"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 7 approved and 4 investigational indications."}
{"id":"CHEMBL214502","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2ccc(O)cc2)c1Br","inchiKey":"QZWUMLLRAVGBHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL214502","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2165224","canonicalSmiles":"CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@@H](O)C2","inchiKey":"WTQYWNWRJNXDEG-RBZJEDDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISODAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anisodamine"],"crossReferences":{"drugbank":["DB11785"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2218885","canonicalSmiles":"C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC.C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)OC)c(CCC(=O)O)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC","inchiKey":"NJLRKAMQPVVOIU-IXZGEAKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERTEPORFIN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Visudyne"],"synonyms":["CL 318,952","CL-318952","Verteporfin"],"crossReferences":{"DailyMed":["verteporfin"],"DrugCentral":["2816"]},"count":14,"approvedIndications":["EFO_0004683","EFO_0005753"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for ocular vascular disease and wet macular degeneration and has 12 investigational indications."}
{"id":"CHEMBL221959","canonicalSmiles":"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12","inchiKey":"UJLAWZDWDVHWOW-YPMHNXCESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOFACITINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["550","CP 690550","CP- 690 550","CP-690","CP-690,550","CP-690,550 FREE BASE","CP-690-550","CP-690550","CP-690550 FREE BASE","CP690,550","CP690550","Tasocitinib","Tofacitinib"],"crossReferences":{"DailyMed":["tofacitinib%20citrate"],"PubChem":["124939204","50100095"],"Wikipedia":["Tofacitinib"],"drugbank":["DB08895"],"chEBI":["71200"]},"childChemblIds":["CHEMBL2103743"],"count":22,"approvedIndications":["EFO_0000540"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003086","EFO_1001494","EFO_0003778","EFO_0000274","EFO_0000540","EFO_0002690","EFO_0003884","EFO_0000676","EFO_0004991","EFO_0000717","EFO_0003921","Orphanet_797","EFO_0000685","EFO_1001857","EFO_1000906","EFO_0003898","MONDO_0019558","EFO_0000384","EFO_0002609","EFO_0003106","EFO_0000546","EFO_0003834","MONDO_0100096","EFO_0004192","EFO_0000398","MONDO_0019472","EFO_0000699"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for immune system disease and has 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL227924","canonicalSmiles":"NC[C@@H](c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1","inchiKey":"HWVGILTYGZFGLR-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227924","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364633","canonicalSmiles":"CON(C)Cc1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cl","inchiKey":"APPRLAGZQKOUFL-FIPJBXKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARECYCLINE HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2364632","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Seysara"],"synonyms":["P-00562","PO-05672","PO05672","Sarecycline hydrochloride","WC-3035","WC3035"],"crossReferences":{"DailyMed":["sarecycline%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for acne."}
{"id":"CHEMBL242580","canonicalSmiles":"Cc1cc(C2CCCCC2)n(O)c(=O)c1.NCCO","inchiKey":"MBRHNTMUYWQHMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLOPIROX OLAMINE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1413","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loprox","Mycoster"],"synonyms":["Ciclopirox ethanolamine salt (1:1)","Ciclopirox olamine","HOE 296","HOE-296","NSC-336278"],"crossReferences":{"PubChem":["11113028","124882753","144204332","170464708","26747930","460263","56463527"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL251634","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO","inchiKey":"GAKMQHDJQHZUTJ-ULHLPKEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOCORTOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ficoid 2","Ficoid 2-plus","Ultradil","Ultralanum","Ultraproct"],"synonyms":["Fluocortolone","SH 742"],"crossReferences":{"Wikipedia":["Fluocortolone"],"drugbank":["DB08971"]},"count":1,"approvedIndications":["EFO_0009552"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for hemorrhoid."}
{"id":"CHEMBL251932","canonicalSmiles":"Oc1c(Br)cc(-c2nc3ccccc3o2)cc1Br","inchiKey":"DMOJYCAJRLAKQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL251932","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08206"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL254316","canonicalSmiles":"Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1","inchiKey":"CZFFBEXEKNGXKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALTEGRAVIR","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isentress"],"synonyms":["MK-0518","Raltegravir"],"crossReferences":{"DailyMed":["raltegravir%20potassium"],"PubChem":["124896574","170466888"],"Wikipedia":["Raltegravir"],"drugbank":["DB06817"]},"childChemblIds":["CHEMBL1162988","CHEMBL518520","CHEMBL4567874","CHEMBL460566"],"count":12,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for viral disease and has 11 investigational indications."}
{"id":"CHEMBL257662","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(OP(=O)(O)O)cc1[C@@H](NC(C)=O)CC2","inchiKey":"UGBMEXLBFDAOGL-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZD-6126","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANG 453","ANG-453","AZD 6126","AZD-6126","ZD 6126","ZD-6126","ZM 445526","ZM-445526","Zd-6126","Zd6126"],"crossReferences":{"drugbank":["DB11872"]},"childChemblIds":["CHEMBL4067484"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL273348","canonicalSmiles":"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1","inchiKey":"WUWFMDMBOJLQIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOSUFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBOTT-61827","Ozex","Tosufloxacin","Tosufloxacin tosilate"],"crossReferences":{"PubChem":["124893342","50112789"],"Wikipedia":["Tosufloxacin"],"chEBI":["77581"]},"childChemblIds":["CHEMBL542832","CHEMBL104270"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL277577","canonicalSmiles":"O=c1[nH]c(=O)n(COCCO)cc1Cc1cccc(OCc2ccccc2)c1","inchiKey":"CSXNPJKDZKLDET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL277577","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06873"],"chEBI":["39579"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278894","canonicalSmiles":"CC(C)(C)Nc1nc(C(F)(F)F)nc2ccc(-c3cccc(N)c3)cc12","inchiKey":"XQKJVNGGVLHNLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL278894","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07612"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282686","canonicalSmiles":"CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O","inchiKey":"CXGTZJYQWSUFET-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESAGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Galida"],"synonyms":["AR-H-039242","AR-H039242XX","AZ-242","Az-242","BR-44608","Tesaglitazar"],"crossReferences":{"drugbank":["DB06536"]},"count":1,"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL290744","canonicalSmiles":"C[C@H](CC(=O)O)[C@H](N)C(=O)O","inchiKey":"FHJNAFIJPFGZRI-WUJLRWPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL290744","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03810"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL293405","canonicalSmiles":"Cc1ncnc2nc[nH]c12","inchiKey":"SYMHUEFSSMBHJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL293405","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124899121"],"drugbank":["DB02113"],"chEBI":["40274"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL294029","canonicalSmiles":"C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"OPAHEYNNJWPQPX-RCDICMHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVUCONAZOLE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-207147","ER-30346","Ravuconazole"],"crossReferences":{"Wikipedia":["Ravuconazole"],"drugbank":["DB06440"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL296306","canonicalSmiles":"OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"JCQLYHFGKNRPGE-FCVZTGTOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTULOSE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acilac","Bifiteral","Cephulac","Cholac","Chronulac","Constilac","Constulose","Duphalac","Duphalac dry","Enulose","Evalose","Generlac","Heptalac","Lactulose","Laxilose","Laxose orange","Lemlax","Osmolax","Portalac","Regulose"],"synonyms":["E966","Lactulose","Lactulose jp17"],"crossReferences":{"DailyMed":["lactulose"],"PubChem":["144204871","170464861","26754430"],"Wikipedia":["Lactulose"],"drugbank":["DB00581"],"chEBI":["6359"]},"childChemblIds":["CHEMBL1237068"],"count":4,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for constipation and has 3 investigational indications."}
{"id":"CHEMBL306226","canonicalSmiles":"c1ccc2[nH]cnc2c1","inchiKey":"HYZJCKYKOHLVJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZIMIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1H-Benzimidazole","1H-Benzo[D]Imidazole","1H-Benzoimidazole","Benzimidazole","NSC-759"],"crossReferences":{"PubChem":["144209305","144213638","47193726"],"Wikipedia":["Benzimidazole"],"drugbank":["DB02962"],"chEBI":["41275"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL309282","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc4cc(C(=O)O)ccc4c3)ccc21","inchiKey":"RWYREGSYPCNZTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL309282","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL315985","canonicalSmiles":"NC(=O)N1c2ccccc2C[C@H](O)c2ccccc21","inchiKey":"BMPDWHIDQYTSHX-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESLICARBAZEPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erelib","Pazzul","Stedesa"],"synonyms":["BIA 2-194","BIA-2-194","CGP-13751","Eslicarbazepine"],"crossReferences":{"drugbank":["DB14575"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL3182813","canonicalSmiles":"CCN(CC)C(=S)[S-].CCN(CC)C(=S)[S-].[Zn+2]","inchiKey":"RKQOSDAEEGPRER-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182813","maximumClinicalTrialPhase":0,"parentId":"CHEMBL961","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207461"],"drugbank":["DB14193"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184437","canonicalSmiles":"OCc1ccc(Cl)cc1Cl","inchiKey":"DBHODFSFBXJZNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROBENZYL ALCOHOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dichlorobenzyl alcohol"],"crossReferences":{"PubChem":["144211212","170465574"],"drugbank":["DB13269"],"chEBI":["48220"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3186475","canonicalSmiles":"CC(O)CCO","inchiKey":"PUPZLCDOIYMWBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186475","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209606","144210405"],"drugbank":["DB14110"],"chEBI":["52683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186492","canonicalSmiles":"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O.Cl.O.O","inchiKey":"VRSLTNZJOUZKLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONDANSETRON HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL46","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Demorem","Ondansetron hydrochloride","Ondansetron hydrochloride preservative free","Ondemet","Setofilm","Zofran","Zofran preservative free"],"synonyms":["GR 38032F","GR-38032F","NSC-665799","Ondansetron hydrochloride","Ondansetron hydrochloride dihydrate","Ondansetron hydrochloride hydrate","SN 307","SN-307"],"crossReferences":{"DailyMed":["ondansetron%20hydrochloride"],"PubChem":["144206896"]},"count":7,"approvedIndications":["EFO_0006911","EFO_0004888","HP_0002013"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","Orphanet_79292","EFO_0004888","HP_0002013","EFO_0003843","HP_0002018","EFO_0007386"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL3189137","canonicalSmiles":"CN1CCN(C(c2ccccc2)c2ccccc2)CC1.Cl.Cl","inchiKey":"CKLJCUGYMOMAEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3189137","maximumClinicalTrialPhase":0,"parentId":"CHEMBL648","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144203984","170465270"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3234681","canonicalSmiles":"CC(C)(C)NC(=O)c1nn(-c2ccc(F)cc2F)c2c1[C@H]1CC[C@@H]2C1","inchiKey":"NTPZXHMTJGOMCJ-WDEREUQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDALINAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Grc-10693","Tedalinab"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3250424","canonicalSmiles":"[2H]C1([2H])CC(NC(=O)N(CCCl)N=O)CC([2H])([2H])C1([2H])[2H]","inchiKey":"GQYIWUVLTXOXAJ-NMFSSPJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250424","maximumClinicalTrialPhase":0,"parentId":"CHEMBL514","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3251336","canonicalSmiles":"O=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12","inchiKey":"UUGITDASWNOAGG-CCXZUQQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3251336","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04627"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301570","drugType":"Unknown","blackBoxWarning":false,"name":"NECUPARANIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-402 FREE ACID","Necuparanib"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL351298","canonicalSmiles":"N=C(N)c1cccc(CN2CCN(S(=O)(=O)c3cc4ccc(Cl)cc4s3)CC2=O)c1","inchiKey":"PRMSFVUWLBPPLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL351298","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08487"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545013","drugType":"Small molecule","blackBoxWarning":false,"name":"APN1125","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apn1125"],"count":1,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0000692"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545121","drugType":"Small molecule","blackBoxWarning":false,"name":"EPITINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epitinib","Hmpl-813"],"count":2,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000519"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545290","drugType":"Small molecule","blackBoxWarning":false,"name":"PRS-211375","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prs-211375"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL357995","canonicalSmiles":"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1","inchiKey":"UUOJIACWOAYWEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOPINDOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bopindolol","Bopindolol malonate"],"crossReferences":{"PubChem":["144205570","170466106","26756519"],"Wikipedia":["Bopindolol"],"drugbank":["DB08807"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3581693","canonicalSmiles":"CC/C(=C(/c1ccc(/C=C/C(=O)O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl","inchiKey":"BURHGPHDEVGCEZ-KJGLQBJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRILANESTRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARN-810","Brilanestrant","GDC-0810","Gdc-0810","RG-6046","RG6046"],"crossReferences":{"drugbank":["DB12253"]},"count":1,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL361497","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","inchiKey":"FIHJKUPKCHIPAT-AHIGJZGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTESUNATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arsumax"],"synonyms":["Artesunate","NSC-712571"],"crossReferences":{"drugbank":["DB09274"],"chEBI":["63918"]},"childChemblIds":["CHEMBL207675"],"count":10,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for malaria and has 9 investigational indications."}
{"id":"CHEMBL363847","canonicalSmiles":"CN1CCN(CCn2cnc3c(NC4CCCCC4)nc(C#N)nc32)CC1","inchiKey":"OGODDSLNRULSMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL363847","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07965"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3673452","canonicalSmiles":"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)cnc43)cc2OC)cc1","inchiKey":"HVRWZFQFSQUILC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GZ-389988","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GZ-389988","GZ389988","Gz-389988","Gz389988"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707379","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04958242","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-104","PF-04958242","PF-4958242","Pf-04958242"],"count":2,"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["EFO_1001176","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL371315","canonicalSmiles":"NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"JJGBXTYGTKWGAT-YUMQZZPRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"Gly-Pro-Glu","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gly-Pro-Glu"],"crossReferences":{"drugbank":["DB05633"]},"childChemblIds":["CHEMBL4449611"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3753858","canonicalSmiles":"c1cc(-c2nc3ccc(-c4ccc5nc(-c6ccncc6)[nH]c5c4)cc3[nH]2)ccn1","inchiKey":"UHQFBTAJFNVZIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIDINILAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ridinilazole","Smt19969"],"crossReferences":{"drugbank":["DB15308"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL376180","canonicalSmiles":"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1","inchiKey":"TVZGACDUOSZQKY-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOPTERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Aminofolic acid","4-Aminopteroic acid","Aminopterin","Aminopteroylglutamic acid","Methotrexate related compound b","NSC-739"],"crossReferences":{"PubChem":["144203620","144210944"],"drugbank":["DB08878"],"chEBI":["22526"]},"childChemblIds":["CHEMBL2104643"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL379300","canonicalSmiles":"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12","inchiKey":"YWTBGJGMTBHQTM-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-443654","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-443654","A-4436554"],"crossReferences":{"PubChem":["81066752"],"drugbank":["DB08073"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL380394","canonicalSmiles":"O=C(O)c1c(NS(=O)(=O)c2ccccc2)ccc2c1CCCC2","inchiKey":"RRXVUYHFDBLTEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380394","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07322"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL391640","canonicalSmiles":"C/C(=C\\S(=O)(=O)N[C@H]1CCN([C@@H](C)C(=O)N2CCOCC2)C1=O)c1ccc(Cl)s1","inchiKey":"YMJHMJLNQLVUAV-GHYUOPHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391640","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07211"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL393336","canonicalSmiles":"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O=P(O)(O)O","inchiKey":"IQFYVLUXQXSJJN-SBSPUUFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0431","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1422","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0431"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3942449","canonicalSmiles":"CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cl","inchiKey":"HXMCZSICOWSBRX-XGLFQKEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3942449","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1689772","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989866","canonicalSmiles":"O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2","inchiKey":"SOLUWJRYJLAZCX-LYOVBCGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICTEGRAVIR","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bictegravir","GS-9883","GS-9883-01"],"crossReferences":{"DailyMed":["bictegravir%20sodium"],"drugbank":["DB11799"]},"childChemblIds":["CHEMBL3989867"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 investigational indications."}
{"id":"CHEMBL3989979","drugType":"Cell","blackBoxWarning":false,"name":"RIVOGENLECLEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPX-501","Rivogenlecleucel"],"count":4,"description":"Cell drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4063810","canonicalSmiles":"[2H]/C(c1nc[nH]c1C(C)(C)C)=c1/[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O","inchiKey":"UNRCMCRRFYFGFX-JTSGUJNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4063810","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1096380","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4080228","canonicalSmiles":"COc1cc(C)[nH]c(=O)c1CN1CCc2c(Cl)cc([C@H](OC)C3COC3)c(Cl)c2C1=O","inchiKey":"RXCVUHMIWHRLDF-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06821497","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06821497","Pf-06821497"],"crossReferences":{"drugbank":["DB14799"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4092143","canonicalSmiles":"CCOC(=O)N1CCC(=[14C]2c3ccc(Cl)cc3CCc3cccnc32)CC1","inchiKey":"JCCNYMKQOSZNPW-ZWXVIAAOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4092143","maximumClinicalTrialPhase":0,"parentId":"CHEMBL998","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4100200","canonicalSmiles":"[2H]c1cc(C(=O)NC)c(F)c([2H])c1N1C(=S)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=O)C12CCC2","inchiKey":"HJBWBFZLDZWPHF-IVMPHTLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4100200","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3183409","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4105630","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CC[C@@](C)(O)C[C@H]4CC[C@H]3[C@@H]1CC[C@@H]2C(=O)Cn1cc(C#N)cn1","inchiKey":"HARRKNSQXBRBGZ-GVKWWOCJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZURANOLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-812217","SAGE-217","SGE-797","Sage-217","Zuranolone"],"crossReferences":{"drugbank":["DB15490"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL427342","canonicalSmiles":"O=C(Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1","inchiKey":"SCEVFJUWLLRELN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDOCARB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidocarb","MMV665810","TCMDC-124304"],"crossReferences":{"drugbank":["DB11521"],"chEBI":["51804"]},"childChemblIds":["CHEMBL590893","CHEMBL1315701","CHEMBL3989411","CHEMBL1362780"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428462","canonicalSmiles":"Clc1ccc(C2(c3ccc(-c4cn[nH]c4)cc3)CCNCC2)cc1","inchiKey":"LZMOSYUFVYJEPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL428462","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07859"],"chEBI":["82708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297337","canonicalSmiles":"[11CH3]OCc1cccnc1N1CCN(C[C@H]2COc3ccccc3O2)CC1","inchiKey":"VGIYMYGMVXPMKV-GWDMYEQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORM-13070 C-11","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4302506","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(11C)ORM-13070","11C-ORM-13070","11c-orm-13070","Orm-13070 c-11"],"crossReferences":{"drugbank":["DB15324"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297351","canonicalSmiles":"C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2Cc1ccc2nc(Br)cnc2c1","inchiKey":"ALANRBCCCQEPFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATX-914","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AXT914","Atx-914","Axt914"],"crossReferences":{"drugbank":["DB12673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297359","canonicalSmiles":"COc1c(C)cnc(Cn2cc(C#CCCOP(=O)(O)O)c3c(Cl)nc(N)nc32)c1C","inchiKey":"BMZGPNGECPQAGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIIB-028","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB028","Biib-028","Biib028"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297393","canonicalSmiles":"C/C1=C/C[C@@H](/C(C)=C/c2cc(C)on2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\\C1","inchiKey":"JAYGOFBXDFAXBW-CYEKYUJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KOSN-1724","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iso-fludelone","Kosn-1724"],"crossReferences":{"drugbank":["DB13078"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297468","canonicalSmiles":"COc1ccc([C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC2=CCCC2)C(=O)[C@@]2(C)CO2)cc1","inchiKey":"GHYOCDFICYLMRF-UTIIJYGPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"KZR-616","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KZR-616","Kzr-616"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297706","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986179","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986179","BMS986179","Bms 986179","Bms-986179"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297739","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"DANVATIRSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD 9150","AZD-9150","AZD9150","Azd9150","Danvatirsen","ISIS-481464","ISIS-STAT3RX"],"count":7,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297773","drugType":"Unknown","blackBoxWarning":false,"name":"ITI-214","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iti-214"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297924","drugType":"Unknown","blackBoxWarning":false,"name":"POWDERED CELLULOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cellulose","E-460(II)","INS NO.460(II)","INS-460(II)","Powdered cellulose"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298126","drugType":"Unknown","blackBoxWarning":false,"name":"VON WILLEBRAND FACTOR HUMAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Von willebrand factor","Von willebrand factor human"],"count":4,"approvedIndications":["MP_0001914"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 3 investigational indications."}
{"id":"CHEMBL4298180","drugType":"Cell","blackBoxWarning":false,"name":"DARVADSTROCEL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alofisel"],"synonyms":["CX-601","Cx601","Darvadstrocel"],"count":2,"approvedIndications":["EFO_0000540"],"description":"Cell drug with a maximum clinical trial phase of IV (across all indications) and is indicated for immune system disease and has 1 investigational indication."}
{"id":"CHEMBL4298199","drugType":"Gene","blackBoxWarning":false,"name":"IDECABTAGENE VICLEUCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-2121","Idecabtagene vicleucel","bb2121"],"count":1,"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298211","drugType":"Protein","blackBoxWarning":false,"name":"PEGCETACOPLAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APL-2","Pegcetacoplan"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4299940","canonicalSmiles":"O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CC2)CC1","inchiKey":"XAYGBKHKBBXDAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITAPIVAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-348","Ag-348","Mitapivat"],"childChemblIds":["CHEMBL4297223"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL431701","canonicalSmiles":"COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@@H]2CO)ccc1O","inchiKey":"SEBFKMXJBCUCAI-HKTJVKLFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILYBIN A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-651520","Silybin a","Silymarin"],"crossReferences":{"PubChem":["144204621","144207953","170466469","17388738","50086851"],"drugbank":["DB09298"],"chEBI":["9144"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL435298","canonicalSmiles":"C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"SYTBZMRGLBWNTM-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESFLURBIPROFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTS 24332","BTS-24332","Esflurbiprofen"],"crossReferences":{"PubChem":["47193727"],"chEBI":["42446"]},"count":1,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0030839","EFO_0009582"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4524943","canonicalSmiles":"COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12.O=C(O)C(F)(F)F","inchiKey":"SDKIEVIZDIGZIP-UNCJQMLCSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4524943","maximumClinicalTrialPhase":0,"parentId":"CHEMBL376488","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4567874","canonicalSmiles":"[2H]C([2H])([2H])c1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1","inchiKey":"CZFFBEXEKNGXKS-FIBGUPNXSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4567874","maximumClinicalTrialPhase":0,"parentId":"CHEMBL254316","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594260","canonicalSmiles":"Br.CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1","inchiKey":"UQRICAQPWZSJNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZEMETOSTAT HYDROBROMIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3414621","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tazverik"],"synonyms":["EPZ-6438 HYDROBROMIDE","EZ438","Tazemetostat hydrobromide"],"crossReferences":{"DailyMed":["tazemetostat%20hydrobromide"]},"count":1,"approvedIndications":["EFO_0000691"],"linkedTargets":{"rows":["ENSG00000106462"],"count":1},"linkedDiseases":{"rows":["EFO_0000691"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for sarcoma."}
{"id":"CHEMBL4594396","canonicalSmiles":"Nc1ncnc2c1nc(Cl)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"MHDPPLULTMGBSI-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-CHLOROADENOSINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-chloroadenosine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594452","canonicalSmiles":"CCCCCCCCC=CCCCCCCC(O)C(=O)O","inchiKey":"JBSOOFITVPOOSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-HYDROXYOLEIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-hydroxyoleic acid","2-ohoa"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594494","drugType":"Unknown","blackBoxWarning":false,"name":"SC-005","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-005","SC005","Sc-005"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594510","drugType":"Unknown","blackBoxWarning":false,"name":"VRC07-523LS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VRC07-523LS","VRC07523LS","Vrc07-523ls"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL47386","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@H](O)C2","inchiKey":"XMOCLSLCDHWDHP-IUODEOHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPIGALLOCATECHIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Epigallocatechin","Epigallocatechin"],"crossReferences":{"PubChem":["515468"],"Wikipedia":["Gallocatechol"],"drugbank":["DB03823"],"chEBI":["42255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"OROGSEYTTFOCAN-DNJOTXNNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CODEINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Codeine","Codeine monohydrate","IDS-NC-005(SECT.-2)"],"crossReferences":{"DailyMed":["codeine%20phosphate","codeine%20polistirex","codeine%20sulfate"],"PubChem":["144207280"],"Wikipedia":["Codeine"],"drugbank":["DB00318"],"chEBI":["16714"]},"childChemblIds":["CHEMBL4297091","CHEMBL1257022","CHEMBL284671","CHEMBL1159819","CHEMBL369475","CHEMBL1201463","CHEMBL1201099"],"count":8,"approvedIndications":["HP_0012735","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012532","Orphanet_232","HP_0012735","EFO_0003821","EFO_0010072","HP_0000545","HP_0000175","EFO_0003843","EFO_0000546","EFO_1001216","EFO_0010282","EFO_0002506","HP_0030833","EFO_0000764","HP_0002019"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for cough and pain and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL504805","canonicalSmiles":"Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1","inchiKey":"HXUZQEYFKAZBPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL504805","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07528"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL509924","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO","inchiKey":"OGPWIDANBSLJPC-RFPWEZLHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLUCORTOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nerisone","Nerisone fte","Temetex"],"synonyms":["Diflucortolone","Diflucortolone valerate"],"crossReferences":{"drugbank":["DB09095"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL520400","canonicalSmiles":"CN1CCC(N(Cc2ccccc2)c2ccccc2)CC1","inchiKey":"VZSXTYKGYWISGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamipine","Piperamine"],"crossReferences":{"PubChem":["170466303"],"Wikipedia":["Bamipine"],"drugbank":["DB13489"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL522157","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1cccc(Br)c1","inchiKey":"VOWXAXNVAGLOGM-NGYBGAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07044"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL528","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1","inchiKey":"NNULBSISHYWZJU-LLKWHZGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTIZOXIME","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefizox","Ceftizoxime","FK-749"],"crossReferences":{"Wikipedia":["Ceftizoxime"],"drugbank":["DB01332"],"chEBI":["553473"]},"childChemblIds":["CHEMBL1201019"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL533","canonicalSmiles":"CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1","inchiKey":"ALOBUEHUHMBRLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IBUTILIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ibutilide"],"crossReferences":{"DailyMed":["ibutilide%20fumarate"],"Wikipedia":["Ibutilide"],"drugbank":["DB00308"],"chEBI":["5856"]},"childChemblIds":["CHEMBL3187455","CHEMBL2355456"],"count":1,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000055118"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","HP_0001657"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and is indicated for cardiac arrhythmia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL544","canonicalSmiles":"COc1ccc(O)cc1","inchiKey":"NWVVVBRKAWDGAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEQUINOL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["4-hydroxyanisole","4-methoxyphenol","4ha","BMS-181158","Hqmme; hydroxyquinone methyl ether","Leucobasal","Leucodine b","Mechinolum","Menthyl anthranilate","Mequinol","Novo-dermoquinona","P-guaiacol","P-hydroxyanisole"],"crossReferences":{"PubChem":["144204676","144209565","144213193","170464687","17389832","50105587","71152","85272557"],"Wikipedia":["Mequinol"],"drugbank":["DB09516"],"chEBI":["69441"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999."}
{"id":"CHEMBL548","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"XEYBRNLFEZDVAW-ARSRFYASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINOPROSTONE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cervidil","Prepidil","Propess","Prostin e2"],"synonyms":["Dinoprostone","Dinoprostone beta-cyclodextrin clathrate","NSC-165560","NSC-196514","Prostaglandin e2","U-12,062","U-12062"],"crossReferences":{"DailyMed":["dinoprostone"],"PubChem":["144204747","170465000","26753268","26753269","26753270","50105679"],"Wikipedia":["Prostaglandin_E2"],"drugbank":["DB00917"],"chEBI":["15551"]},"count":2,"linkedTargets":{"rows":["ENSG00000050628","ENSG00000160951","ENSG00000125384","ENSG00000171522"],"count":4},"linkedDiseases":{"rows":["HP_0001788","EFO_0003843","EFO_0002950"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 2 investigational indications."}
{"id":"CHEMBL55264","canonicalSmiles":"CCCCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"IJEGNOYPWRBKAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL55264","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06830"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561132","canonicalSmiles":"CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1","inchiKey":"JTCAGRAKUAAYDY-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-7246","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-7246"],"childChemblIds":["CHEMBL2093879"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL588","canonicalSmiles":"Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1","inchiKey":"TVURRHSHRRELCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOLDOPAM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fenoldopam","SK&F-82526","SK-82526"],"crossReferences":{"DailyMed":["fenoldopam%20mesylate"],"PubChem":["104171160","144203703","170465321","26752227","50104923","90340762"],"Wikipedia":["Fenoldopam"],"drugbank":["DB00800"],"chEBI":["5002"]},"childChemblIds":["CHEMBL1256646","CHEMBL1026"],"count":4,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000184845"],"count":1},"linkedDiseases":{"rows":["HP_0001919","EFO_0001645","EFO_0000319","EFO_1002048","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL605","canonicalSmiles":"CCN(CC)CCNC(=O)c1ccc(N)cc1.Cl","inchiKey":"ABTXGJFUQRCPNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCAINAMIDE HYDROCHLORIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL640","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biocoryl","Novocainamid","Procainamide hydrochloride","Procan","Procan sr","Procanbid","Procapan","Pronestyl","Pronestyl-sr"],"synonyms":["Procainamide HCl","Procainamide hydrochloride"],"crossReferences":{"DailyMed":["procainamide%20hydrochloride"],"PubChem":["144210053","26747643","50106886","56423113","855728"],"chEBI":["8429"]},"count":2,"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL61","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC","inchiKey":"YJGVMLPVUAXIQN-XVVDYKMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PODOFILOX","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Condyline","Condylox","Podofilox","Warticon"],"synonyms":["NSC-24818","Podofilox","Podophyllotoxin"],"crossReferences":{"DailyMed":["podofilox"],"PubChem":["144204425","144210120","170464788","26751475","26751476","29215001","50103982","50103983","56422495","56463668","855658","86163"],"Wikipedia":["Podophyllotoxin"],"drugbank":["DB01179"],"chEBI":["50305"]},"count":2,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for viral disease and has 1 investigational indication."}
{"id":"CHEMBL654","canonicalSmiles":"CN1CCN2c3ncccc3Cc3ccccc3C2C1","inchiKey":"RONZAEMNMFQXRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIRTAZAPINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mirtazapine","Remeron","Remeron soltab","Zispin"],"synonyms":["Mirtazapine","ORG 3770","ORG-3770"],"crossReferences":{"DailyMed":["mirtazapine"],"PubChem":["144204516","29215050","49648465"],"Wikipedia":["Mirtazapine"],"drugbank":["DB00370"],"chEBI":["6950"]},"count":18,"approvedIndications":["MONDO_0002050","MONDO_0002009","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000102468","ENSG00000150594","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["EFO_0003756","EFO_0004240","EFO_0002610","EFO_0005687","EFO_0006911","MONDO_0002009","HP_0000726","HP_0002039","EFO_0001358","HP_0001824","EFO_0003829","EFO_0008533","EFO_0003890","MONDO_0002050","EFO_0000289","MONDO_0002491","HP_0004326","EFO_0004888","EFO_0003761","EFO_0007634","EFO_0004701","EFO_0005230","EFO_0000692","EFO_0003918"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL738","canonicalSmiles":"CCCC(C)C1(CC)C(=O)N=C([S-])NC1=O.[Na+]","inchiKey":"AWLILQARPMWUHA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPENTAL SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL441","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intraval","Intraval sod","Penthiobarbital","Pentothal","Thiomebumal","Thionembutal","Thiopentone","Trapanal"],"synonyms":["Thiomebumal sodium","Thiopental Sodium","Thiopental sodium"],"crossReferences":{"PubChem":["144205294","170464734","26749790"],"Wikipedia":["Sodium_thiopental"],"chEBI":["9561"]},"count":1,"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_1001454","EFO_0001645"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL810","canonicalSmiles":"Cn1nnc2c(C(N)=O)ncn2c1=O","inchiKey":"BPEGJWRSRHCHSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TEMOZOLOMIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Temodal","Temodar","Temomedac","Temozolomide"],"synonyms":["CCRG-81045","M&B 39831","M&B-39831","M-39831","NSC-362856","SCH 52365","SCH-52365","Temozolomide"],"crossReferences":{"DailyMed":["temozolomide"],"PubChem":["170464968","174007391","26719845","465959","50112683","99355753"],"Wikipedia":["Temozolomide"],"drugbank":["DB00853"],"chEBI":["72564"]},"count":67,"approvedIndications":["EFO_0000616","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for neoplasm and cancer and has 65 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL861","canonicalSmiles":"CCC1(c2ccccc2)NC(=O)N(C)C1=O","inchiKey":"GMHKMTDVRCWUDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENYTOIN","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mesantoin"],"synonyms":["Mephenytoin","Methoin"],"crossReferences":{"PubChem":["56463168"],"Wikipedia":["Mephenytoin"],"drugbank":["DB00532"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for epilepsy."}
{"id":"CHEMBL87045","canonicalSmiles":"c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1","inchiKey":"IPOBOOXFSRWSHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIFENLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cibenzoline","Cibenzoline succinate","Cifenline","RO 22-7796"],"crossReferences":{"PubChem":["26755692","90341191"],"Wikipedia":["Cibenzoline"],"drugbank":["DB13358"]},"childChemblIds":["CHEMBL2106074","CHEMBL3189111"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL92404","canonicalSmiles":"C[C@H](O)[C@@H](CCOc1ccc2ccccc2c1)n1cnc(C(N)=O)c1","inchiKey":"UYAJDVNLQJVRHD-SCLBCKFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL92404","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07785"]},"childChemblIds":["CHEMBL544550"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL939","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1","inchiKey":"XGALLCVXEZPNRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEFITINIB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iressa"],"synonyms":["Gefitinib","Iressa","ZD-1839","ZD1839"],"crossReferences":{"DailyMed":["gefitinib"],"PubChem":["103905343","103905344","124892204","124892206","137275808","144205236","170464828","29215403","50100103"],"Wikipedia":["Gefitinib"],"drugbank":["DB00317"],"chEBI":["49668"]},"count":48,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003859","MONDO_0004192","EFO_0000571","EFO_0000681","MONDO_0021117","EFO_1001465","MONDO_0007254","EFO_0001071","EFO_0004252","EFO_0000708","MONDO_0002087","EFO_0000308","MONDO_0020654","EFO_1001951","MONDO_0001187","EFO_0000178","MONDO_0002158","EFO_1001480","EFO_0000588","MONDO_0002974","MONDO_0002898","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0000196","EFO_0000514","EFO_0000707","EFO_1000158","EFO_0000616","EFO_0003897","EFO_0002618","EFO_0006859","MONDO_0008170","MONDO_0004669","MONDO_0007576","EFO_0000313","EFO_0000222","EFO_0003060","MONDO_0008315","EFO_0000621","EFO_0000311","EFO_0009260","EFO_0006861","EFO_1001100","EFO_0004284","EFO_0000233","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0000519"],"count":53},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 45 investigational indications."}
{"id":"CHEMBL9514","canonicalSmiles":"COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1","inchiKey":"KYRVNWMVYQXFEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOCODAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nocodazole","R 17,934"],"crossReferences":{"PubChem":["104171185","11111427","11111428","11113976","124880639","124880641","124880643","134122","144203740","170466087","26747163","26752117","26752118","46500439","49667696","50104774","85231125","90341042"],"Wikipedia":["Nocodazole"],"drugbank":["DB08313"],"chEBI":["34892"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
